AbbVie to Present at the Evercore ISI HealthCONx Conference

Rhea-AI Summary

AbbVie (NYSE: ABBV) will present at the 5th Annual Evercore ISI Virtual HealthCONx Conference on November 29, 2022, at 9:55 a.m. Central time. Key executives including Rob Michael, Jeffrey R. Stewart, Scott Reents, and Tom Hudson will participate in the session. Investors can access a live audio webcast through AbbVie's Investor Relations website, with an archived version available later that day. AbbVie focuses on innovative medicines across various therapeutic areas, including immunology and oncology.

NORTH CHICAGO, Ill., Nov. 23, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 5^th Annual Evercore ISI Virtual HealthCONx Conference on Tuesday, November 29, 2022. Rob Michael, vice chairman and president, Jeffrey R. Stewart, executive vice president, commercial operations, Scott Reents, senior vice president and chief financial officer, and Tom Hudson senior vice president, R&D and chief scientific officer, will present at 9:55 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and women's health, in addition to products and services across our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

 

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-evercore-isi-healthconx-conference-301685385.html

SOURCE AbbVie

FAQ

When will AbbVie present at the Evercore ISI Virtual HealthCONx Conference?

AbbVie will present at the Evercore ISI Virtual HealthCONx Conference on November 29, 2022.

Who will represent AbbVie at the HealthCONx Conference?

Rob Michael, Jeffrey R. Stewart, Scott Reents, and Tom Hudson will represent AbbVie at the conference.

What time is AbbVie's presentation at the conference?

AbbVie's presentation is scheduled for 9:55 a.m. Central time.

Where can I find the webcast of AbbVie's presentation?

The live audio webcast can be accessed on AbbVie's Investor Relations website.

What is AbbVie’s focus in terms of therapeutic areas?

AbbVie focuses on immunology, oncology, neuroscience, eye care, virology, and women's health.